Palliative Interventions in Advanced Cholangiocarcinoma

Abstract

Patients with advanced cholangiocarcinoma have poor prognosis and often experience severe tumor-related symptoms. Malignant biliary obstruction and cancer pain are common complications associated with advanced cholangiocarcinoma. We review percutaneous palliative interventions that can improve quality of life for these patients.

Keywords

biliary obstruction - cancer pain - palliative intervention - ablation

Publikationsverlauf

Eingereicht: 22. April 2024

Angenommen: 09. Mai 2024

Artikel online veröffentlicht:
27. Juni 2024

• References

• 1 Plentz RR, Malek NP. Clinical presentation, risk factors and staging systems of cholangiocarcinoma. Best Pract Res Clin Gastroenterol 2015; 29 (02) 245-252
• 2 Jansen H, Pape UF, Utku N. A review of systemic therapy in biliary tract carcinoma. J Gastrointest Oncol 2020; 11 (04) 770-789
• 3 Valle JW, Borbath I, Khan SA, Huguet F, Gruenberger T, Arnold D. ESMO Guidelines Committee. Biliary cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2016; 27 (Suppl. 05) v28-v37
• 4 Hunter LA, Soares HP. Quality of life and symptom management in advanced biliary tract cancers. Cancers (Basel) 2021; 13 (20) 5074
• 5 Blechacz B, Komuta M, Roskams T, Gores GJ. Clinical diagnosis and staging of cholangiocarcinoma. Nat Rev Gastroenterol Hepatol 2011; 8 (09) 512-522
• 6 Covey AM, Brown KT. Palliative percutaneous drainage in malignant biliary obstruction. Part 1: indications and preprocedure evaluation. J Support Oncol 2006; 4 (06) 269-273
• 7 Andersen JR, Sørensen SM, Kruse A, Rokkjaer M, Matzen P. Randomised trial of endoscopic endoprosthesis versus operative bypass in malignant obstructive jaundice. Gut 1989; 30 (08) 1132-1135
• 8 Lai EC, Chu KM, Lo CY, Fan ST, Lo CM, Wong J. Choice of palliation for malignant hilar biliary obstruction. Am J Surg 1992; 163 (02) 208-212
• 9 Smith AC, Dowsett JF, Russell RC, Hatfield AR, Cotton PB. Randomised trial of endoscopic stenting versus surgical bypass in malignant low bile duct obstruction. Lancet 1994; 344 (8938): 1655-1660
• 10 Paik WH, Park YS, Hwang JH. et al. Palliative treatment with self-expandable metallic stents in patients with advanced type III or IV hilar cholangiocarcinoma: a percutaneous versus endoscopic approach. Gastrointest Endosc 2009; 69 (01) 55-62
• 11 Piñol V, Castells A, Bordas JM. et al. Percutaneous self-expanding metal stents versus endoscopic polyethylene endoprostheses for treating malignant biliary obstruction: randomized clinical trial. Radiology 2002; 225 (01) 27-34
• 12 Saluja SS, Gulati M, Garg PK. et al. Endoscopic or percutaneous biliary drainage for gallbladder cancer: a randomized trial and quality of life assessment. Clin Gastroenterol Hepatol 2008; 6 (08) 944-950.e3
• 13 Mansour JC, Aloia TA, Crane CH, Heimbach JK, Nagino M, Vauthey JN. Hilar cholangiocarcinoma: expert consensus statement. HPB (Oxford) 2015; 17 (08) 691-699
• 14 Okamoto T, Fujioka S, Yanagisawa S. et al. Placement of a metallic stent across the main duodenal papilla may predispose to cholangitis. Gastrointest Endosc 2006; 63 (06) 792-796
• 15 Deipolyi AR, Covey AM. Palliative percutaneous biliary interventions in malignant high bile duct obstruction. Semin Intervent Radiol 2017; 34 (04) 361-368
• 16 Takayasu K, Muramatsu Y, Shima Y, Moriyama N, Yamada T, Makuuchi M. Hepatic lobar atrophy following obstruction of the ipsilateral portal vein from hilar cholangiocarcinoma. Radiology 1986; 160 (02) 389-393
• 17 Hadjis NS, Adam A, Gibson R, Blenkharn JI, Benjamin IS, Blumgart LH. Nonoperative approach to hilar cancer determined by the atrophy-hypertrophy complex. Am J Surg 1989; 157 (04) 395-399
• 18 Friesen BR, Gibson RN, Speer T, Vincent JM, Stella D, Collier NA. Lobar and segmental liver atrophy associated with hilar cholangiocarcinoma and the impact of hilar biliary anatomical variants: a pictorial essay. Insights Imaging 2011; 2 (05) 525-531
• 19 Perez-Johnston R, Deipolyi AR, Covey AM. Percutaneous biliary interventions. Gastroenterol Clin North Am 2018; 47 (03) 621-641
• 20 Chang WH, Kortan P, Haber GB. Outcome in patients with bifurcation tumors who undergo unilateral versus bilateral hepatic duct drainage. Gastrointest Endosc 1998; 47 (05) 354-362
• 21 Inal M, Akgül E, Aksungur E, Seydaoğlu G. Percutaneous placement of biliary metallic stents in patients with malignant hilar obstruction: unilobar versus bilobar drainage. J Vasc Interv Radiol 2003; 14 (11) 1409-1416
• 22 Sutter CM, Ryu RK. Percutaneous management of malignant biliary obstruction. Tech Vasc Interv Radiol 2015; 18 (04) 218-226
• 23 Thornton RH, Frank BS, Covey AM. et al. Catheter-free survival after primary percutaneous stenting of malignant bile duct obstruction. AJR Am J Roentgenol 2011; 197 (03) W514-8
• 24 Maybody M, Brown KT, Brody LA. et al. Primary patency of Wallstents in malignant bile duct obstruction: single vs. two or more noncoaxial stents. Cardiovasc Intervent Radiol 2009; 32 (04) 707-713
• 25 Inal M, Aksungur E, Akgül E, Oguz M, Seydaoglu G. Percutaneous placement of metallic stents in malignant biliary obstruction: one-stage or two-stage procedure? Pre-dilate or not?. Cardiovasc Intervent Radiol 2003; 26 (01) 40-45
• 26 Chatzis N, Pfiffner R, Glenck M, Stolzmann P, Pfammatter T, Sharma P. Comparing percutaneous primary and secondary biliary stenting for malignant biliary obstruction: a retrospective clinical analysis. Indian J Radiol Imaging 2013; 23 (01) 38-45
• 27 Jo JH, Park BH. Suprapapillary versus transpapillary stent placement for malignant biliary obstruction: which is better?. J Vasc Interv Radiol 2015; 26 (04) 573-582
• 28 Huang X, Shen L, Jin Y. et al. Comparison of uncovered stent placement across versus above the main duodenal papilla for malignant biliary obstruction. J Vasc Interv Radiol 2015; 26 (03) 432-437
• 29 Borges AP, Silva AV, Donato P. Comparison between suprapapillary and transpapillary uncovered self-expandable metallic stent placement for perihilar cholangiocarcinoma. J Vasc Interv Radiol 2023; 34 (08) 1400-1408
• 30 Tringali A, Hassan C, Rota M, Rossi M, Mutignani M, Aabakken L. Covered vs. uncovered self-expandable metal stents for malignant distal biliary strictures: a systematic review and meta-analysis. Endoscopy 2018; 50 (06) 631-641
• 31 Saad WEA, Wallace MJ, Wojak JC, Kundu S, Cardella JF. Quality improvement guidelines for percutaneous transhepatic cholangiography, biliary drainage, and percutaneous cholecystostomy. J Vasc Interv Radiol 2010; 21 (06) 789-795
• 32 Quencer KB, Tadros AS, Marashi KB. et al. Bleeding after percutaneous transhepatic biliary drainage: incidence, causes and treatments. J Clin Med 2018; 7 (05) 94
• 33 Venkatanarasimha N, Damodharan K, Gogna A. et al. Diagnosis and management of complications from percutaneous biliary tract interventions. Radiographics 2017; 37 (02) 665-680
• 34 Caterino JM, Adler D, Durham DD. et al. Analysis of diagnoses, symptoms, medications, and admissions among patients with cancer presenting to emergency departments. JAMA Netw Open 2019; 2 (03) e190979
• 35 Tsai SC, Liu LN, Tang ST, Chen JC, Chen ML. Cancer pain as the presenting problem in emergency departments: incidence and related factors. Support Care Cancer 2010; 18 (01) 57-65
• 36 Coyne CJ, Reyes-Gibby CC, Durham DD. et al. Cancer pain management in the emergency department: a multicenter prospective observational trial of the Comprehensive Oncologic Emergencies Research Network (CONCERN). Support Care Cancer 2021; 29 (08) 4543-4553
• 37 Sullivan DR, Chan B, Lapidus JA. et al. Association of early palliative care use with survival and place of death among patients with advanced lung cancer receiving care in the Veterans health administration. JAMA Oncol 2019; 5 (12) 1702-1709
• 38 Vargas-Schaffer G. Is the WHO analgesic ladder still valid? Twenty-four years of experience. Can Fam Physician 2010; 56 (06) 514-517 , e202–e205
• 39 NCCN Guidelines Version 2.2024. Adult Cancer Pain. Accessed May 20, 2024 at: https://www.nccn.org/professionals/physician_gls/pdf/pain.pdf
• 40 Elberg Dengsø K, Hillingsø J, Marcussen AM, Thomsen T. Health-related quality of life and anxiety and depression in patients diagnosed with cholangiocarcinoma: a prospective cohort study. Acta Oncol 2017; 56 (02) 198-204
• 41 Kambadakone A, Thabet A, Gervais DA, Mueller PR, Arellano RS. CT-guided celiac plexus neurolysis: a review of anatomy, indications, technique, and tips for successful treatment. Radiographics 2011; 31 (06) 1599-1621
• 42 Eisenberg E, Carr DB, Chalmers TC. Neurolytic celiac plexus block for treatment of cancer pain: a meta-analysis. Anesth Analg 1995; 80 (02) 290-295
• 43 Arcidiacono PGG, Calori G, Carrara S, McNicol ED, Testoni PA. Celiac plexus block for pancreatic cancer pain in adults. Cochrane Database Syst Rev 2011; 2011 (03) CD007519
• 44 Lu F, Li X, Song L, Ye L, Wang X, Wang R. Efficacy and safety of celiac plexus neurolysis versus splanchnic nerve neurolysis in the management of abdominal cancer pain: a meta-analysis of 359 patients. Pain Physician 2024; 27 (01) 1-10
• 45 Key BM, Tutton SM, Scheidt MJ. Cone-beam CT with enhanced needle guidance and augmented fluoroscopy overlay: applications in interventional radiology. AJR Am J Roentgenol 2023; 221 (01) 92-101
• 46 Chary A, Edalat F. Celiac plexus cryoneurolysis. Semin Intervent Radiol 2022; 39 (02) 138-141
• 47 Tsukamoto S, Kido A, Tanaka Y. et al. Current overview of treatment for metastatic bone disease. Curr Oncol 2021; 28 (05) 3347-3372
• 48 Huisman M, van den Bosch MAAJ, Wijlemans JW, van Vulpen M, van der Linden YM, Verkooijen HM. Effectiveness of reirradiation for painful bone metastases: a systematic review and meta-analysis. Int J Radiat Oncol Biol Phys 2012; 84 (01) 8-14
• 49 Jennings JW, Prologo JD, Garnon J. et al. Cryoablation for palliation of painful bone metastases: the MOTION multicenter study. Radiol Imaging Cancer 2021; 3 (02) e200101
• 50 Levy J, David E, Hopkins T. et al. Radiofrequency ablation provides rapid and durable pain relief for the palliative treatment of lytic bone metastases independent of radiation therapy: final results from the OsteoCool tumor ablation post-market study. Cardiovasc Intervent Radiol 2023; 46 (05) 600-609
• 51 Khanmohammadi S, Noroozi A, Yekaninejad MS, Rezaei N. Cryoablation for the palliation of painful bone metastasis: a systematic review. Cardiovasc Intervent Radiol 2023; 46 (11) 1469-1482
• 52 Kurup AN, Morris JM, Callstrom MR. Ablation of musculoskeletal metastases. AJR Am J Roentgenol 2017; 209 (04) 713-721